Scientific exchange · Dr. Emiko Tanaka

13 Apr 2026 · Phone · Dr. Emiko Tanaka, Uniklinik Köln · MSL James Whitfield · Vantrexa

ReviewedVeeva CRMENG-0008—

Capture insight from this engagement

Location: Uniklinik Köln
Therapeutic area: Oncology
Country: Germany
Stakeholder tier: Tier 1
Strategic objective: Not linked
Initiative: Not linked
MSL: JWJames WhitfieldSenior MSL, Oncology (US East)
Product: Vantrexa (vantrelimab)

Topics discussed

Elderly / ECOG 2 patients
Duration of response
Comparator checkpoint monotherapy

Scientific content used

PD-L1 testing pathway infographic

Questions raised

No questions recorded.

Notes

Scientific exchange with thoracic medical oncologist at Uniklinik Köln. Discussed elderly / ecog 2 patients, duration of response, comparator checkpoint monotherapy.

Insights captured (1)

Capture insight

INS-0029High
Elderly / ECOG 2 patients
Elderly / ECOG 2 patients: gap in current materials reported by thoracic medical oncologist (DE).
Closed

Review workflow

Draft
Submitted
3Reviewed

Review complete. Quality ratings and insights can now be used in aggregates.

Follow-ups

No follow-ups recorded.

Quality ratings

1–5, rated at review

Scientific relevance: 5
Strategic relevance: 4
Depth of exchange: 3
Actionability: 1

Data lineage

Source system: Veeva CRM
Sync: Veeva CRM · synced 2026-09-15 08:00 UTC
System of record: Veeva CRM
Record id: ENG-0008

Audit history (0)

All create, update and approval events for this record

No audit events in sample data